Lilly Plans to Build a New $6.5 Billion Facility to Manufacture Active Pharmaceutical Ingredients in Texas
Eli Lilly and Company announced that it plans to build a new $6.5 billion manufacturing facility at Generation Park in Houston, Texas. This planned next-generation synthetic medicine active pharmaceutical product (API) facility, the second of four new U.S. sites Lilly will announce this year, is expected to be operational within five years. Lilly will bring 615 new high-wage jobs to the Greater Houston area, including…